Glia in the pathogenesis of neurodegenerative diseases

Biochemical Society Transactions

Volumn 42, Issue 5, 2014, Pages 1291-1301

  Verkhratsky, Alexei ^a,b,c   Parpura, Vladimir ^d,e   Pekna, Marcela ^f,g   Pekny, Milos ^f,g   Sofroniew, Michael ^h  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b BASQUE FOUNDATION FOR SCIENCE   (Spain)

^c LOBACHEVSKY STATE UNIVERSITY OF NIZHNY NOVGOROD   (Russian Federation)

^d University of Alabama at Birmingham   (United States)

^e University of Rijeka   (Croatia)

^f UNIVERSITY OF GOTHENBURG   (Sweden)

^g FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; Glia; Huntington's disease; Neurodegeneration; Parkinson's disease

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; VIMENTIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ASTHENIA; ASTROCYTE; BRAIN DEVELOPMENT; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; COGNITION; DEGENERATIVE DISEASE; GLIA; GLIOSIS; HOMEOSTASIS; HUNTINGTON CHOREA; MICROGLIA; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROTRANSMISSION; NONHUMAN; OLIGODENDROGLIA; PARKINSON DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SYNAPTIC TRANSMISSION; ANIMAL; BIOLOGICAL MODEL; HUMAN; PATHOLOGY;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ASTROCYTES; GLIOSIS; HUMANS; HUNTINGTON DISEASE; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES; NEUROGLIA; PARKINSON DISEASE;

EID: 84907169653     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20140107     Document Type: Review

References (146)

1. Parpura, V., Heneka, M.T., Montana, V., Oliet, S.H., Schousboe, A., Haydon, P.G., Stout, Jr, R.F., Spray, D.C., Reichenbach, A., Pannicke, T. et al. (2012) Glial cells in (patho)physiology. J. Neurochem. 121, 4-27 CrossRef PubMed
2. Kettenmann, H. and Ransom, B.R. (2013) Neuroglia, Oxford University Press, Oxford
3. Verkhratsky, A. and Butt, A.M. (2013) Glial Physiology and Pathophysiology, Wiley-Blackwell, Chichester CrossRef
4. Zhou, Y. and Danbolt, N.C. (2013) GABA and glutamate transporters in brain. Front. Endocrinol. 4, 165 CrossRef
5. Eulenburg, V. and Gomeza, J. (2010) Neurotransmitter transporters expressed in glial cells as regulators of synapse function. Brain Res. Rev. 63, 103-112 CrossRef PubMed
6. Boison, D., Chen, J.F. and Fredholm, B.B. (2010) Adenosine signaling and function in glial cells. Cell Death Differ. 17, 1071-1082 CrossRef PubMed
7. Hertz, L. and Zielke, H.R. (2004) Astrocytic control of glutamatergic activity: astrocytes as stars of the show. Trends Neurosci. 27, 735-743 CrossRef PubMed
8. Rose, C.F., Verkhratsky, A. and Parpura, V. (2013) Astrocyte glutamine synthetase: pivotal in health and disease. Biochem. Soc. Trans. 41, 1518-1524 CrossRef PubMed
9. Abbott, N.J., Patabendige, A.A., Dolman, D.E., Yusof, S.R. and Begley, D.J. (2010) Structure and function of the blood-brain barrier. Neurobiol. Dis. 37, 13-25 CrossRef PubMed
10. Mathiisen, T.M., Lehre, K.P., Danbolt, N.C. and Ottersen, O.P. (2010) The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction. Glia 58, 1094-1103 CrossRef PubMed
11. Iadecola, C. and Nedergaard, M. (2007) Glial regulation of the cerebral microvasculature. Nat. Neurosci. 10, 1369-1376 CrossRef PubMed
12. Gourine, A.V. and Kasparov, S. (2011) Astrocytes as brain interoceptors. Exp. Physiol. 96, 411-416 PubMed
13. Blutstein, T. and Haydon, P.G. (2013) The importance of astrocyte-derived purines in the modulation of sleep. Glia 61, 129-139 CrossRef PubMed
14. Halassa, M.M., Dal Maschio, M., Beltramo, R., Haydon, P.G., Benfenati, F. and Fellin, T. (2010) Integrated brain circuits: neuron-astrocyte interaction in sleep-related rhythmogenesis. ScientificWorldJournal 10, 1634-1645 CrossRef PubMed
15. Zatorre, R.J., Fields, R.D. and Johansen-Berg, H. (2012) Plasticity in gray and white: neuroimaging changes in brain structure during learning. Nat. Neurosci. 15, 528-536 CrossRef PubMed
16. Fields, R.D. (2008) White matter in learning, cognition and psychiatric disorders. Trends Neurosci. 31, 361-370 CrossRef PubMed
17. Fields, R.D. (2008) Oligodendrocytes changing the rules: action potentials in glia and oligodendrocytes controlling action potentials. Neuroscientist 14, 540-543 CrossRef PubMed
18. Du, Y. and Dreyfus, C.F. (2002) Oligodendrocytes as providers of growth factors. J. Neurosci. Res. 68, 647-654 CrossRef PubMed
19. Yamazaki, Y., Hozumi, Y., Kaneko, K., Fujii, S., Goto, K. and Kato, H. (2010) Oligodendrocytes: facilitating axonal conduction by more than myelination. Neuroscientist 16, 11-18 CrossRef PubMed
20. Richardson, W.D., Young, K.M., Tripathi, R.B. and McKenzie, I. (2011) NG2-glia as multipotent neural stem cells: fact or fantasy? Neuron 70, 661-673 CrossRef PubMed
21. Nishiyama, A., Komitova, M., Suzuki, R. and Zhu, X. (2009) Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat. Rev. Neurosci. 10, 9-22 CrossRef PubMed
22. Butt, A.M., Kiff, J., Hubbard, P. and Berry, M. (2002) Synantocytes: new functions for novel NG2 expressing glia. J. Neurocytol. 31, 551-565 CrossRef PubMed
23. Kierdorf, K., Erny, D., Goldmann, T., Sander, V., Schulz, C., Perdiguero, E.G., Wieghofer, P., Heinrich, A., Riemke, P., Holscher, C. et al. (2013) Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat. Neurosci. 16, 273-280 CrossRef PubMed
24. Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M.F., Conway, S.J., Ng, L.G., Stanley, E.R. et al. (2010) Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841-845 CrossRef PubMed
25. Nimmerjahn, A., Kirchhoff, F. and Helmchen, F. (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314-1318 CrossRef PubMed
26. Kettenmann, H., Hanisch, U.K., Noda, M. and Verkhratsky, A. (2011) Physiology of microglia. Physiol. Rev. 91, 461-553 CrossRef PubMed
27. Parkhurst, C.N., Yang, G., Ninan, I., Savas, J.N., Yates, III, J.R., Lafaille, J.J., Hempstead, B.L., Littman, D.R. and Gan, W.B. (2013) Microglia promote learning-dependent synapse formation through brainderived neurotrophic factor. Cell 155, 1596-1609 CrossRef PubMed
28. Tremblay, M.E., Stevens, B., Sierra, A., Wake, H., Bessis, A. and Nimmerjahn, A. (2011) The role of microglia in the healthy brain. J. Neurosci. 31, 16064-16069 CrossRef PubMed
29. Kettenmann, H., Kirchhoff, F. and Verkhratsky, A. (2013) Microglia: new roles for the synaptic stripper. Neuron 77, 10-18 CrossRef PubMed
30. Suh, S.W., Bergher, J.P., Anderson, C.M., Treadway, J.L., Fosgerau, K. and Swanson, R.A. (2007) Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-R&z.ast;,S&z.ast;]-5-chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1H-indole-2-carboxamide). J. Pharmacol. Exp. Ther. 321, 45-50 CrossRef PubMed
31. Burda, J.E. and Sofroniew, M.V. (2014) Reactive gliosis and the multicellular response to CNS damage and disease. Neuron 81, 229-248 CrossRef PubMed
32. Giaume, C., Kirchhoff, F., Matute, C., Reichenbach, A. and Verkhratsky, A. (2007) Glia: the fulcrum of brain diseases. Cell Death Differ. 14, 1324-1335 CrossRef PubMed
33. Hanisch, U.K. and Kettenmann, H. (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387-1394 CrossRef PubMed
34. Pekna, M. and Pekny, M. (2012) The neurobiology of brain injury. Cerebrum 2012, 9 PubMed
35. Pekny, M., Wilhelmsson, U. and Pekna, M. (2014) The dual role of astrocyte activation and reactive gliosis. Neurosci. Lett. 565, 30-38 CrossRef PubMed
36. Sofroniew, M.V. (2009) Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 32, 638-647 CrossRef PubMed
37. Sofroniew, M.V. and Vinters, H.V. (2010) Astrocytes: biology and pathology. Acta Neuropathol. 119, 7-35 CrossRef PubMed
38. Pekny, M. and Nilsson, M. (2005) Astrocyte activation and reactive gliosis. Glia 50, 427-434 CrossRef PubMed
39. Robel, S., Berninger, B. and Gotz, M. (2011) The stem cell potential of glia: lessons from reactive gliosis. Nat. Rev. Neurosci. 12, 88-104 CrossRef PubMed
40. Tripathi, R.B., Rivers, L.E., Young, K.M., Jamen, F. and Richardson, W.D. (2010) NG2 glia generate new oligodendrocytes but few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease. J. Neurosci. 30, 16383-16390 CrossRef PubMed
41. Zawadzka, M., Rivers, L.E., Fancy, S.P., Zhao, C., Tripathi, R., Jamen, F., Young, K., Goncharevich, A., Pohl, H., Rizzi, M. et al. (2010) CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. Cell Stem. Cell 6, 578-590 CrossRef PubMed
42. Ransohoff, R.M. and Perry, V.H. (2009) Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 27, 119-145 CrossRef PubMed
43. Boche, D., Perry, V.H. and Nicoll, J.A. (2013) Review: activation patterns of microglia and their identification in the human brain. Neuropathol. Appl. Neurobiol. 39, 3-18 CrossRef PubMed
44. De Keyser, J., Mostert, J.P. and Koch, M.W. (2008) Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders. J. Neurol. Sci. 267, 3-16 CrossRef PubMed
45. Verkhratsky, A., Rodríguez, J.J. and Parpura, V. (2013) Astroglia in neurological diseases. Future Neurol. 8, 149-158 CrossRef PubMed
46. Verkhratsky, A., Olabarria, M., Noristani, H.N., Yeh, C.Y. and Rodríguez, J.J. (2010) Astrocytes in Alzheimer's disease. Neurotherapeutics 7, 399-412 CrossRef PubMed
47. Zeidan-Chulia, F., Salmina, A.B., Malinovskaya, N.A., Noda, M., Verkhratsky, A. and Moreira, J.C. (2014) The glial perspective of autism spectrum disorders. Neurosci. Biobehav. Rev. 38, 160-172 CrossRef PubMed
48. Verkhratsky, A., Rodríguez, J.J. and Steardo, L. (2013) Astrogliopathology: a central element of neuropsychiatric diseases? Neuroscientist, doi:10.1177/1073858413510208 PubMed
49. Charcot, J.M. (1881) Amyotrophic lateral sclerosis: symptomatology. In Lectures on Diseases of the Nervous System, pp. 192-204, New Sydenham Society, London
50. Charcot, J.M. and Joffroy, A. (1869) Deux cas d'atrophie musculaire progressive avec lesions de la substance grise et de faisceaux anterolateraux de la moelle epiniere. Arch. Physiol. Norm. Pathol. 1, 354-367
51. Gordon, P.H. (2013) Amyotrophic lateral sclerosis: an update for 2013 clinical features, pathophysiology, management and therapeutic trials. Aging Dis. 4, 295-310 CrossRef PubMed
52. Turner, B.J. and Talbot, K. (2008) Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog. Neurobiol. 85, 94-134 CrossRef PubMed
53. Valori, C.F., Brambilla, L., Martorana, F. and Rossi, D. (2014) The multifaceted role of glial cells in amyotrophic lateral sclerosis. Cell. Mol. Life Sci. 71, 287-297 CrossRef PubMed
54. Rossi, D., Brambilla, L., Valori, C.F., Roncoroni, C., Crugnola, A., Yokota, T., Bredesen, D.E. and Volterra, A. (2008) Focal degeneration of astrocytes in amyotrophic lateral sclerosis. Cell Death Differ. 15, 1691-1700 CrossRef PubMed
55. Rossi, D. and Volterra, A. (2009) Astrocytic dysfunction: insights on the role in neurodegeneration. Brain Res. Bull. 80, 224-232 CrossRef PubMed
56. Yamanaka, K., Chun, S.J., Boillee, S., Fujimori-Tonou, N., Yamashita, H., Gutmann, D.H., Takahashi, R., Misawa, H. and Cleveland, D.W. (2008) Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 11, 251-253 CrossRef PubMed
57. Re, D. B., Le Verche, V., Yu, C., Amoroso, M. W., Politi, K. A., Phani, S., Ikiz, B., Hoffmann, L., Koolen, M., Nagata, T. et al. (2014) Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron 81, 1001-1008 CrossRef PubMed
58. Staats, K.A. and Van Den Bosch, L. (2009) Astrocytes in amyotrophic lateral sclerosis: direct effects on motor neuron survival. J. Biol. Phys. 35, 337-346 CrossRef PubMed
59. Turner, M.R., Cagnin, A., Turkheimer, F.E., Miller, C.C.J. and Shaw, C.E. (2004) Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study 1. Neurobiol. Dis. 15, 601-609 CrossRef PubMed
60. Beers, D.R., Henkel, J.S., Xiao, Q., Zhao, W.H., Wang, J.H., Yen, A.A., Siklos, L., McKercher, S.R. and Appel, S.H. (2006) Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 103, 16021-16026 CrossRef PubMed
61. Boillee, S., Yamanaka, K., Lobsiger, C.S., Copeland, N.G., Jenkins, N.A., Kassiotis, G., Kollias, G. and Cleveland, D.W. (2006) Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 1389-1392 CrossRef PubMed
62. Heneka, M.T., Rodríguez, J.J. and Verkhratsky, A. (2010) Neuroglia in neurodegeneration. Brain Res. Rev. 63, 189-211 CrossRef PubMed
63. Beauquis, J., Pavia, P., Pomilio, C., Vinuesa, A., Podlutskaya, N., Galvan, V. and Saravia, F. (2013) Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer's disease. Exp. Neurol. 239, 28-37 CrossRef PubMed
64. Kulijewicz-Nawrot, M., Verkhratsky, A., Chvatal, A., Sykova, E. and Rodríguez, J.J. (2012) Astrocytic cytoskeletal atrophy in the medial prefrontal cortex of a triple transgenic mouse model of Alzheimer's disease. J. Anat. 221, 252-262 CrossRef PubMed
65. Olabarria, M., Noristani, H.N., Verkhratsky, A. and Rodríguez, J.J. (2010) Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease. Glia 58, 831-838 PubMed
66. Olabarria, M., Noristani, H.N., Verkhratsky, A. and Rodríguez, J.J. (2011) Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer's disease mouse model: mechanism for deficient glutamatergic transmission? Mol. Neurodegener. 6, 55 CrossRef PubMed
67. Rodríguez, J.J., Olabarria, M., Chvatal, A. and Verkhratsky, A. (2009) Astroglia in dementia and Alzheimer's disease. Cell Death Differ. 16, 378-385 CrossRef PubMed
68. Rodríguez, J.J., Terzieva, S., Olabarria, M., Lanza, R.G. and Verkhratsky, A. (2013) Enriched environment and physical activity reverse astrogliodegeneration in the hippocampus of AD transgenic mice. Cell Death Dis. 4, e678 CrossRef PubMed
69. Rodríguez, J.J. and Verkhratsky, A. (2011) Neuroglial roots of neurodegenerative diseases? Mol. Neurobiol. 43, 87-96 CrossRef PubMed
70. Yeh, C.Y., Vadhwana, B., Verkhratsky, A. and Rodríguez, J.J. (2011) Early astrocytic atrophy in the entorhinal cortex of a triple transgenic animal model of Alzheimer's disease. ASN NEURO 3, 271-279 CrossRef PubMed
71. Beauquis, J., Vinuesa, A., Pomilio, C., Pavia, P., Galvan, V. and Saravia, F. (2014) Neuronal and glial alterations, increased anxiety, and cognitive impairment before hippocampal amyloid deposition in PDAPP mice, model of Alzheimer's disease. Hippocampus 24, 257-269 CrossRef PubMed
72. Oddo, S., Caccamo, A., Shepherd, J.D., Murphy, M.P., Golde, T.E., Kayed, R., Metherate, R., Mattson, M.P., Akbari, Y. and LaFerla, F.M. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 39, 409-421 CrossRef PubMed
73. Bell, R.D. and Zlokovic, B.V. (2009) Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol. 118, 103-113 CrossRef PubMed
74. Zlokovic, B.V. (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178-201 CrossRef PubMed
75. Mosconi, L., Pupi, A. and De Leon, M.J. (2008) Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease. Ann. N.Y. Acad. Sci. 1147, 180-195 CrossRef PubMed
76. Mrak, R.E., Sheng, J.G. and Griffin, W.S. (1995) Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum. Pathol. 26, 816-823 CrossRef PubMed
77. Wyss-Coray, T. (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat. Med. 12, 1005-1015 PubMed
78. Wyss-Coray, T., Loike, J.D., Brionne, T.C., Lu, E., Anankov, R., Yan, F., Silverstein, S.C. and Husemann, J. (2003) Adult mouse astrocytes degrade amyloid-â in vitro and in situ. Nat. Med. 9, 453-457 CrossRef PubMed
79. Koistinaho, M., Lin, S., Wu, X., Esterman, M., Koger, D., Hanson, J., Higgs, R., Liu, F., Malkani, S., Bales, K.R. et al. (2004) Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-â peptides. Nat. Med. 10, 719-726 CrossRef PubMed
80. Hyder, C.L., Isoniemi, K.O., Torvaldson, E.S. and Eriksson, J.E. (2011) Insights into intermediate filament regulation from development to ageing. J. Cell Sci. 124, 1363-1372 CrossRef PubMed
81. Pekny, M. and Lane, E.B. (2007) Intermediate filaments and stress. Exp. Cell Res. 313, 2244-2254 CrossRef PubMed
82. Eliasson, C., Sahlgren, C., Berthold, C.H., Stakeberg, J., Celis, J.E., Betsholtz, C., Eriksson, J.E. and Pekny, M. (1999) Intermediate filament protein partnership in astrocytes. J. Biol. Chem. 274, 23996-24006 CrossRef PubMed
83. Pekny, M., Johansson, C.B., Eliasson, C., Stakeberg, J., Wallen, A., Perlmann, T., Lendahl, U., Betsholtz, C., Berthold, C.H. and Frisen, J. (1999) Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin. J. Cell Biol. 145, 503-514 CrossRef PubMed
84. Lundkvist, A., Reichenbach, A., Betsholtz, C., Carmeliet, P., Wolburg, H. and Pekny, M. (2004) Under stress, the absence of intermediate filaments from Muller cells in the retina has structural and functional consequences. J. Cell Sci. 117, 3481-3488 CrossRef PubMed
85. Verardo, M.R., Lewis, G.P., Takeda, M., Linberg, K.A., Byun, J., Luna, G., Wilhelmsson, U., Pekny, M., Chen, D.F. and Fisher, S.K. (2008) Abnormal reactivity of muller cells after retinal detachment in mice deficient in GFAP and vimentin. Invest. Ophthalmol. Vis. Sci. 49, 3659-3665 CrossRef PubMed
86. Li, L., Lundkvist, A., Andersson, D., Wilhelmsson, U., Nagai, N., Pardo, A.C., Nodin, C., Stahlberg, A., Aprico, K., Larsson, K. et al. (2008) Protective role of reactive astrocytes in brain ischemia. J. Cereb. Blood Flow Metab. 28, 468-481 CrossRef PubMed
87. Wilhelmsson, U., Li, L., Pekna, M., Berthold, C.H., Blom, S., Eliasson, C., Renner, O., Bushong, E., Ellisman, M., Morgan, T.E. et al. (2004) Absence of glial fibrillary acidic protein and vimentin prevents hypertrophy of astrocytic processes and improves post-traumatic regeneration. J. Neurosci. 24, 5016-5021 CrossRef PubMed
88. Menet, V., Prieto, M., Privat, A. and Gimenez y Ribotta, M. (2003) Axonal plasticity and functional recovery after spinal cord injury in mice deficient in both glial fibrillary acidic protein and vimentin genes. Proc. Natl. Acad. Sci. U.S.A. 100, 8999-9004 CrossRef PubMed
89. Wilhelmsson, U., Faiz, M., de Pablo, Y., Sjoqvist, M., Andersson, D., Widestrand, A., Potokar, M., Stenovec, M., Smith, P.L., Shinjyo, N. et al. (2012) Astrocytes negatively regulate neurogenesis through the Jagged1-mediated Notch pathway. Stem Cells 30, 2320-2329 CrossRef PubMed
90. Larsson, A., Wilhelmsson, U., Pekna, M. and Pekny, M. (2004) Increased cell proliferation and neurogenesis in the hippocampal dentate gyrus of old GFAP -/- Vim -/- mice. Neurochem. Res. 29, 2069-2073 CrossRef PubMed
91. Kinouchi, R., Takeda, M., Yang, L., Wilhelmsson, U., Lundkvist, A., Pekny, M. and Chen, D.F. (2003) Robust neural integration from retinal transplants in mice deficient in GFAP and vimentin. Nat. Neurosci. 6, 863-868 CrossRef PubMed
92. Widestrand, A., Faijerson, J., Wilhelmsson, U., Smith, P.L., Li, L., Sihlbom, C., Eriksson, P.S. and Pekny, M. (2007) Increased neurogenesis and astrogenesis from neural progenitor cells grafted in the hippocampus of GFAP -/- Vim -/- mice. Stem Cells 25, 2619-2627 CrossRef PubMed
93. Kraft, A.W., Hu, X., Yoon, H., Yan, P., Xiao, Q., Wang, Y., Gil, S.C., Brown, J., Wilhelmsson, U., Restivo, J.L. et al. (2013) Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice. FASEB J. 27, 187-198 CrossRef PubMed
94. Yin, K.J., Cirrito, J.R., Yan, P., Hu, X., Xiao, Q., Pan, X., Bateman, R., Song, H., Hsu, F.F., Turk, J. et al. (2006) Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-β peptide catabolism. J. Neurosci. 26, 10939-10948 CrossRef PubMed
95. Askarova, S., Yang, X., Sheng, W., Sun, G.Y. and Lee, J.C. (2011) Role of Aβ-receptor for advanced glycation endproducts interaction in oxidative stress and cytosolic phospholipase A2 activation in astrocytes and cerebral endothelial cells. Neuroscience 199, 375-385 CrossRef PubMed
96. Armulik, A., Genove, G., Mae, M., Nisancioglu, M.H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K. et al. (2010) Pericytes regulate the blood-brain barrier. Nature 468, 557-561 CrossRef PubMed
97. Zlokovic, B.V. (2011) Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 12, 723-738 PubMed
98. Yamaguchi, H., Sugihara, S., Ogawa, A., Saido, T.C. and Ihara, Y. (1998) Diffuse plaques associated with astroglial amyloid β protein, possibly showing a disappearing stage of senile plaques. Acta Neuropathol. 95, 217-222 CrossRef PubMed
99. Hofmann, S.L., Das, A.K., Lu, J.Y., Wisniewski, K.E. and Gupta, P. (2001) Infantile neuronal ceroid lipofuscinosis: no longer just a 'Finnish' disease. Eur. J. Paediatr. Neurol. 5 (Suppl. A), 47-51 PubMed
100. Hofmann, S.L., Das, A.K., Yi, W., Lu, J.Y. and Wisniewski, K.E. (1999) Genotype-phenotype correlations in neuronal ceroid lipofuscinosis due to palmitoyl-protein thioesterase deficiency. Mol. Genet. Metab. 66, 234-239 CrossRef PubMed
101. Vesa, J., Hellsten, E., Verkruyse, L.A., Camp, L.A., Rapola, J., Santavuori, P., Hofmann, S.L. and Peltonen, L. (1995) Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 376, 584-587 CrossRef PubMed
102. Kielar, C., Maddox, L., Bible, E., Pontikis, C.C., Macauley, S.L., Griffey, M.A., Wong, M., Sands, M.S. and Cooper, J.D. (2007) Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis. Neurobiol. Dis. 25, 150-162 CrossRef PubMed
103. Macauley, S.L., Wozniak, D.F., Kielar, C., Tan, Y., Cooper, J.D. and Sands, M.S. (2009) Cerebellar pathology and motor deficits in the palmitoyl protein thioesterase 1-deficient mouse. Exp. Neurol. 217, 124-135 CrossRef PubMed
104. Gupta, P., Soyombo, A.A., Atashband, A., Wisniewski, K.E., Shelton, J.M., Richardson, J.A., Hammer, R.E. and Hofmann, S.L. (2001) Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice. Proc. Natl. Acad. Sci. U.S.A. 98, 13566-13571 CrossRef PubMed
105. Macauley, S.L., Pekny, M. and Sands, M.S. (2011) The role of attenuated astrocyte activation in infantile neuronal ceroid lipofuscinosis. J. Neurosci. 31, 15575-15585 CrossRef PubMed
106. Nakazawa, T., Takeda, M., Lewis, G.P., Cho, K.S., Jiao, J., Wilhelmsson, U., Fisher, S.K., Pekny, M., Chen, D.F. and Miller, J.W. (2007) Attenuated glial reactions and photoreceptor degeneration after retinal detachment in mice deficient in glial fibrillary acidic protein and vimentin. Invest. Ophthalmol. Vis. Sci. 48, 2760-2768 CrossRef PubMed
107. Herrmann, J.E., Imura, T., Song, B., Qi, J., Ao, Y., Nguyen, T.K., Korsak, R.A., Takeda, K., Akira, S. and Sofroniew, M.V. (2008) STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J. Neurosci. 28, 7231-7243 CrossRef PubMed
108. Okada, S., Nakamura, M., Katoh, H., Miyao, T., Shimazaki, T., Ishii, K., Yamane, J., Yoshimura, A., Iwamoto, Y., Toyama, Y. et al. (2006) Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat. Med. 12, 829-834 CrossRef PubMed
109. Wanner, I.B., Anderson, M.A., Song, B., Levine, J., Fernandez, A., Gray-Thompson, Z., Ao, Y. and Sofroniew, M.V. (2013) Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury. J. Neurosci. 33, 12870-12886 CrossRef PubMed
110. Zamanian, J.L., Xu, L., Foo, L.C., Nouri, N., Zhou, L., Giffard, R.G. and Barres, B.A. (2012) Genomic analysis of reactive astrogliosis. J. Neurosci. 32, 6391-6410 CrossRef PubMed
111. MacDonald, M.E., Ambrose, C.M., Duyao, M.P., Myers, R.H., Lin, C., Srinidhi, L., Barnes, G., Taylor, S.A., James, M., Groot, N. et al. (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983 CrossRef PubMed
112. Zoghbi, H.Y. and Orr, H.T. (2000) Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci. 23, 217-247 CrossRef PubMed
113. Andrew, S.E., Goldberg, Y.P., Kremer, B., Telenius, H., Theilmann, J., Adam, S., Starr, E., Squitieri, F., Lin, B., Kalchman, M.A. et al. (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat. Genet. 4, 398-403 CrossRef PubMed
114. Duyao, M., Ambrose, C., Myers, R., Novelletto, A., Persichetti, F., Frontali, M., Folstein, S., Ross, C., Franz, M., Abbott, M. et al. (1993) Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat. Genet. 4, 387-392 CrossRef PubMed
115. Quarrell, O.W., Rigby, A.S., Barron, L., Crow, Y., Dalton, A., Dennis, N., Fryer, A.E., Heydon, F., Kinning, E., Lashwood, A. et al. (2007) Reduced penetrance alleles for Huntington's disease: a multi-centre direct observational study. J. Med. Genet. 44, e68 CrossRef PubMed
116. Rubinsztein, D.C., Leggo, J., Coles, R., Almqvist, E., Biancalana, V., Cassiman, J.J., Chotai, K., Connarty, M., Crauford, D., Curtis, A. et al. (1996) Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am. J. Hum. Genet. 59, 16-22 PubMed
117. Snell, R.G., MacMillan, J.C., Cheadle, J.P., Fenton, I., Lazarou, L.P., Davies, P., MacDonald, M.E., Gusella, J.F., Harper, P.S. and Shaw, D.J. (1993) Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat. Genet. 4, 393-397 CrossRef PubMed
118. Hedreen, J.C., Peyser, C.E., Folstein, S.E. and Ross, C.A. (1991) Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci. Lett. 133, 257-261 CrossRef PubMed
119. Vonsattel, J.P., Myers, R.H., Stevens, T.J., Ferrante, R.J., Bird, E.D. and Richardson, Jr, E.P. (1985) Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559-577 PubMed
120. Gu, X., Andre, V.M., Cepeda, C., Li, S.H., Li, X.J., Levine, M.S. and Yang, X.W. (2007) Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease. Mol. Neurodegener. 2, 8 CrossRef PubMed
121. Gu, X., Li, C., Wei, W., Lo, V., Gong, S., Li, S.H., Iwasato, T., Itohara, S., Li, X.J., Mody, I. et al. (2005) Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice. Neuron 46, 433-444 CrossRef PubMed
122. Singhrao, S.K., Thomas, P., Wood, J.D., MacMillan, J.C., Neal, J.W., Harper, P.S. and Jones, A.L. (1998) Huntingtin protein colocalizes with lesions of neurodegenerative diseases: an investigation in Huntington's, Alzheimer's, and Pick's diseases. Exp. Neurol. 150, 213-222 CrossRef PubMed
123. Faideau, M., Kim, J., Cormier, K., Gilmore, R., Welch, M., Auregan, G., Dufour, N., Guillermier, M., Brouillet, E., Hantraye, P. et al. (2010) In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects. Hum. Mol. Genet. 19, 3053-3067 CrossRef PubMed
124. Vonsattel, J.P. and DiFiglia, M. (1998) Huntington disease. J. Neuropathol. Exp. Neurol. 57, 369-384 PubMed
125. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S.W. et al. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506 CrossRef PubMed
126. Behrens, P.F., Franz, P., Woodman, B., Lindenberg, K.S. and Landwehrmeyer, G.B. (2002) Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain 125, 1908-1922 CrossRef PubMed
127. Lievens, J.C., Woodman, B., Mahal, A., Spasic-Boscovic, O., Samuel, D., Kerkerian-Le Goff, L. and Bates, G.P. (2001) Impaired glutamate uptake in the R6 Huntington's disease transgenic mice. Neurobiol. Dis. 8, 807-821 CrossRef PubMed
128. Arzberger, T., Krampfl, K., Leimgruber, S. and Weindl, A. (1997) Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease: an in situ hybridization study. J. Neuropathol. Exp. Neurol. 56, 440-454 PubMed
129. Hassel, B., Tessler, S., Faull, R.L. and Emson, P.C. (2008) Glutamate uptake is reduced in prefrontal cortex in Huntington's disease. Neurochem. Res. 33, 232-237 CrossRef PubMed
130. Shin, J.Y., Fang, Z.H., Yu, Z.X., Wang, C.E., Li, S.H. and Li, X.J. (2005) Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J. Cell Biol. 171, 1001-1012 CrossRef PubMed
131. Maragakis, N.J. and Rothstein, J.D. (2001) Glutamate transporters in neurologic disease. Arch. Neurol. 58, 365-370 CrossRef PubMed
132. Lee, W., Reyes, R.C., Gottipati, M.K., Lewis, K., Lesort, M., Parpura, V. and Gray, M. (2013) Enhanced Ca2+-dependent glutamate release from astrocytes of the BACHD Huntington's disease mouse model. Neurobiol. Dis. 58, 192-199 CrossRef PubMed
133. Gray, M., Shirasaki, D.I., Cepeda, C., Andre, V.M., Wilburn, B., Lu, X.H., Tao, J., Yamazaki, I., Li, S.H., Sun, Y.E. et al. (2008) Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J. Neurosci. 28, 6182-6195 CrossRef PubMed
134. Menalled, L., El-Khodor, B.F., Patry, M., Suarez-Farinas, M., Orenstein, S.J., Zahasky, B., Leahy, C., Wheeler, V., Yang, X.W., MacDonald, M. et al. (2009) Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models. Neurobiol. Dis. 35, 319-336 CrossRef PubMed
135. Tong, X., Ao, Y., Faas, G.C., Nwaobi, S.E., Xu, J., Haustein, M.D., Anderson, M.A., Mody, I., Olsen, M.L., Sofroniew, M.V. et al. (2014) Astrocyte Kir 4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice. Nat. Neurosci. 17, 694-703 CrossRef PubMed
136. Menalled, L.B., Kudwa, A.E., Miller, S., Fitzpatrick, J., Watson-Johnson, J., Keating, N., Ruiz, M., Mushlin, R., Alosio, W., McConnell, K. et al. (2012) Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175. PLoS ONE 7, e49838 CrossRef PubMed
137. McGeer, P.L. and McGeer, E.G. (2008) Glial reactions in Parkinson's disease. Mov. Disord. 23, 474-483 CrossRef PubMed
138. Forno, L.S., DeLanney, L.E., Irwin, I., Di Monte, D. and Langston, J.W. (1992) Astrocytes and Parkinson's disease. Prog. Brain Res. 94, 429-436 CrossRef PubMed
139. Mirza, B., Hadberg, H., Thomsen, P. and Moos, T. (2000) The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease. Neuroscience 95, 425-432 CrossRef PubMed
140. Sriram, K., Benkovic, S.A., Hebert, M.A., Miller, D.B. and O'Callaghan, J.P. (2004) Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo? J. Biol. Chem. 279, 19936-19947 CrossRef PubMed
141. Episcopo, F.L., Tirolo, C., Testa, N., Caniglia, S., Morale, M.C. and Marchetti, B. (2013) Reactive astrocytes are key players in nigrostriatal dopaminergic neurorepair in the MPTP mouse model of Parkinson's disease: focus on endogenous neurorestoration. Curr. Aging Sci. 6, 45-55 CrossRef PubMed
142. Di Monte, D.A., Royland, J.E., Irwin, I. and Langston, J.W. (1996) Astrocytes as the site for bioactivation of neurotoxins. Neurotoxicology 17, 697-703 PubMed
143. Przedborski, S., Jackson-Lewis, V., Djaldetti, R., Liberatore, G., Vila, M., Vukosavic, S. and Almer, G. (2000) The parkinsonian toxin MPTP: action and mechanism. Restor. Neurol. Neurosci. 16, 135-142 PubMed
144. Chen, P.C., Vargas, M.R., Pani, A.K., Smeyne, R.J., Johnson, D.A., Kan, Y.W. and Johnson, J.A. (2009) Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte. Proc. Natl. Acad. Sci. U.S.A. 106, 2933-2938 CrossRef PubMed
145. Saijo, K., Winner, B., Carson, C.T., Collier, J.G., Boyer, L., Rosenfeld, M.G., Gage, F.H. and Glass, C.K. (2009) A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137, 47-59 CrossRef PubMed
146. Song, Y.J.C., Halliday, G.M., Holton, J.L., Lashley, T., O'Sullivan, S.S., McCann, H., Lees, A.J., Ozawa, T., Williams, D.R., Lockhart, P.J. et al. (2009) Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression. J. Neuropathol. Exp. Neurol. 68, 1073-1083 PubMed